BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

226 related articles for article (PubMed ID: 7679040)

  • 1. Irradiation in relapsing carcinoma of the prostate.
    Perez CA; Cosmatos D; Garcia DM; Eisbruch A; Poulter CA
    Cancer; 1993 Feb; 71(3 Suppl):1110-22. PubMed ID: 7679040
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Salvage reirradiation for locoregional failure after radiation therapy for prostate cancer: who, when, where and how?
    Créhange G; Roach M; Martin E; Cormier L; Peiffert D; Cochet A; Chapet O; Supiot S; Cosset JM; Bolla M; Chung HT
    Cancer Radiother; 2014 Oct; 18(5-6):524-34. PubMed ID: 25192626
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Does Choline PET/CT Change the Management of Prostate Cancer Patients With Biochemical Failure?
    Goldstein J; Even-Sapir E; Ben-Haim S; Saad A; Spieler B; Davidson T; Berger R; Weiss I; Appel S; Lawrence YR; Symon Z
    Am J Clin Oncol; 2017 Jun; 40(3):256-259. PubMed ID: 25319322
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Radiotherapy for palliation of symptoms in incurable cancer.
    Hoegler D
    Curr Probl Cancer; 1997; 21(3):129-83. PubMed ID: 9202888
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Localized carcinoma of the prostate (stages T1B, T1C, T2, and T3). Review of management with external beam radiation therapy.
    Perez CA; Hanks GE; Leibel SA; Zietman AL; Fuks Z; Lee WR
    Cancer; 1993 Dec; 72(11):3156-73. PubMed ID: 7694785
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The palliation of osseous metastasis with 32P or 89Sr compared with external beam and hemibody irradiation: a historical perspective.
    Montebello JF; Hartson-Eaton M
    Cancer Invest; 1989; 7(2):139-60. PubMed ID: 2477119
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long-term outcomes after high-dose postprostatectomy salvage radiation treatment.
    Goenka A; Magsanoc JM; Pei X; Schechter M; Kollmeier M; Cox B; Scardino PT; Eastham JA; Zelefsky MJ
    Int J Radiat Oncol Biol Phys; 2012 Sep; 84(1):112-8. PubMed ID: 22300563
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Multiparametric Magnetic Resonance Imaging Is an Independent Predictor of Salvage Radiotherapy Outcomes After Radical Prostatectomy.
    Sharma V; Nehra A; Colicchia M; Westerman ME; Kawashima A; Froemming AT; Kwon ED; Mynderse LA; Karnes RJ
    Eur Urol; 2018 Jun; 73(6):879-887. PubMed ID: 29195777
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Radiation therapy for the treatment of locally advanced and metastatic prostate cancer.
    Thurman SA; Ramakrishna NR; DeWeese TL
    Hematol Oncol Clin North Am; 2001 Jun; 15(3):423-43. PubMed ID: 11525289
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Functional and oncological outcome of salvage prostatectomy of locally recurrent prostate cancer following radiation therapy].
    Heidenreich A; Ohlmann C; Ozgür E; Engelmann U
    Urologe A; 2006 Apr; 45(4):474-81. PubMed ID: 16465521
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Systemic administration of new therapeutic radioisotopes, including phosphorus, strontium, samarium, and rhenium.
    Porter AT; Ben-Josef E; Davis L
    Curr Opin Oncol; 1994 Nov; 6(6):607-10. PubMed ID: 7827173
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Salvage radiotherapy for men with isolated rising PSA or locally palpable recurrence after radical prostatectomy: do outcomes differ?
    MacDonald OK; Schild SE; Vora S; Andrews PE; Ferrigni RG; Novicki DE; Swanson SK; Wong WW
    Urology; 2004 Oct; 64(4):760-4. PubMed ID: 15491716
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Outcome after conformal salvage radiotherapy in patients with rising prostate-specific antigen levels after radical prostatectomy.
    Geinitz H; Riegel MG; Thamm R; Astner ST; Lewerenz C; Zimmermann F; Molls M; Nieder C
    Int J Radiat Oncol Biol Phys; 2012 Apr; 82(5):1930-7. PubMed ID: 21514736
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Regional hyperthermia in conjunction with definitive radiotherapy against recurrent or locally advanced prostate cancer T3 pN0 M0.
    Tilly W; Gellermann J; Graf R; Hildebrandt B; Weissbach L; Budach V; Felix R; Wust P
    Strahlenther Onkol; 2005 Jan; 181(1):35-41. PubMed ID: 15660191
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Salvage radiotherapy for biochemical and clinical failures following radical prostatectomy.
    Do T; Parker RG; Do C; Tran L; Do L; Dolkar D
    Cancer J Sci Am; 1998; 4(5):324-30. PubMed ID: 9815297
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Radioisotopes for metastatic bone pain.
    Roqué I Figuls M; Martinez-Zapata MJ; Scott-Brown M; Alonso-Coello P
    Cochrane Database Syst Rev; 2011 Jul; (7):CD003347. PubMed ID: 21735393
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Radiotherapy of bone metastases. A review of the literature].
    Simon JM
    Bull Cancer Radiother; 1996; 83(4):290-8. PubMed ID: 9081330
    [No Abstract]   [Full Text] [Related]  

  • 18. [Radical salvage prostatectomy : Treatment of local recurrence of prostate cancer after radiotherapy].
    Heidenreich A; Semrau R; Thüer D; Pfister D
    Urologe A; 2008 Nov; 47(11):1441-6. PubMed ID: 18806991
    [TBL] [Abstract][Full Text] [Related]  

  • 19. 20 Gy versus 44 Gy supplemental beam radiation with Pd-103 prostate brachytherapy: preliminary biochemical outcomes from a prospective randomized multi-center trial.
    Wallner K; Merrick G; True L; Sherertz T; Sutlief S; Cavanagh W; Butler W
    Radiother Oncol; 2005 Jun; 75(3):307-10. PubMed ID: 16086912
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Strontium 89 therapy for the palliation of pain due to osseous metastases.
    Robinson RG; Preston DF; Schiefelbein M; Baxter KG
    JAMA; 1995 Aug; 274(5):420-4. PubMed ID: 7542352
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.